moderate asthma
METHODS: Seventeen children with moderate asthma (aged       between 6 and 13 years, mean 8.76 years) received salmeterol with a spacer device       (Volumatic 200 micrograms daily, b.i.d.) for 3 weeks.
METHODS: Seventeen  @OBJECT$   @PREDICAT$   @SUBJECT$  (aged       between 6 and 13 years, mean 8.76 years) received salmeterol with a spacer device       (Volumatic 200 micrograms daily, b.i.d.) for 3 weeks.